These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31386835)

  • 1. Development of anti-chloro
    Lokeshwaran K; Hemadou A; Jayaprakash NS; Prasanna RR; Jacobin-Valat MJ; Dieryck W; Joucla G; Vijayalakshmi MA; Clofent-Sanchez G; Santarelli X; Venkataraman K
    J Immunol Methods; 2019 Nov; 474():112637. PubMed ID: 31386835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Monoclonal Antibody Against Chlorinated 192tyrosine Containing ApoAI Peptide to Screen Quality of Human High Density Lipoprotein (HDL).
    Lokeshwaran K; Venkataraman K
    Protein Pept Lett; 2016; 23(10):905-912. PubMed ID: 27468813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Characterization of Monoclonal Antibodies Against Nitro-
    Divya G; Jayaprakash NS; Venkataraman K
    Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):167-174. PubMed ID: 30132720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies.
    Kimura H; Mikawa S; Mizuguchi C; Horie Y; Morita I; Oyama H; Ohgita T; Nishitsuji K; Takeuchi A; Lund-Katz S; Akaji K; Kobayashi N; Saito H
    Sci Rep; 2017 Jun; 7(1):2988. PubMed ID: 28592796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.
    Wang XS; Shao B; Oda MN; Heinecke JW; Mahler S; Stocker R
    J Lipid Res; 2009 Mar; 50(3):586-594. PubMed ID: 18832772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
    Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
    Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels.
    Ueda M; Hayase Y; Mashiba S
    Clin Chim Acta; 2007 Mar; 378(1-2):105-11. PubMed ID: 17174291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to plasma high density lipoprotein (HDL) of eel (Anguilla japonica).
    Ndiaye D; Katoh H; Ge YP; Iijima N; Hayashi S
    Comp Biochem Physiol B Biochem Mol Biol; 2000 Apr; 125(4):473-82. PubMed ID: 10904860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.
    DiDonato JA; Aulak K; Huang Y; Wagner M; Gerstenecker G; Topbas C; Gogonea V; DiDonato AJ; Tang WHW; Mehl RA; Fox PL; Plow EF; Smith JD; Fisher EA; Hazen SL
    J Biol Chem; 2014 Apr; 289(15):10276-10292. PubMed ID: 24558038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human apolipoprotein A-I epitopes in high density lipoproteins and in serum.
    Marcel YL; Jewer D; Vézina C; Milthorp P; Weech PK
    J Lipid Res; 1987 Jul; 28(7):768-77. PubMed ID: 2442276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization,
    Gao D; Ashraf MZ; Zhang L; Kar N; Byzova TV; Podrez EA
    J Biol Chem; 2020 Feb; 295(7):1973-1984. PubMed ID: 31907281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
    Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.
    DiDonato JA; Huang Y; Aulak KS; Even-Or O; Gerstenecker G; Gogonea V; Wu Y; Fox PL; Tang WH; Plow EF; Smith JD; Fisher EA; Hazen SL
    Circulation; 2013 Oct; 128(15):1644-55. PubMed ID: 23969698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An abundant dysfunctional apolipoprotein A1 in human atheroma.
    Huang Y; DiDonato JA; Levison BS; Schmitt D; Li L; Wu Y; Buffa J; Kim T; Gerstenecker GS; Gu X; Kadiyala CS; Wang Z; Culley MK; Hazen JE; Didonato AJ; Fu X; Berisha SZ; Peng D; Nguyen TT; Liang S; Chuang CC; Cho L; Plow EF; Fox PL; Gogonea V; Tang WH; Parks JS; Fisher EA; Smith JD; Hazen SL
    Nat Med; 2014 Feb; 20(2):193-203. PubMed ID: 24464187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of the human biliary amphipathic, anionic polypeptide: similarity with a calcium-binding protein isolated from gallstones and bile, and immunologic cross-reactivity with apolipoprotein A-I.
    Domingo N; Grosclaude J; Bekaert ED; Mège D; Chapman MJ; Shimizu S; Ayrault-Jarrier M; Ostrow JD; Lafont H
    J Lipid Res; 1992 Oct; 33(10):1419-30. PubMed ID: 1385560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.